Common Analgesic Agents and Their Roles in Analgesic Nephropathy: A Commentary on the Evidence

키워드

참고문헌 (48)

1. De Broe ME, "Analgesic nephropathy", N Engl J Med, 338, pp.446~452 (1998)
2. Chang SH, "Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes", Clin J Am Soc Nephrol, 3, pp.768~776 (2008)
3. Buckalew VM Jr, "Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence", Medicine (Baltimore), 65, pp.291~303 (1986)
4. De Broe ME, "Over-the-counter analgesic use", J Am Soc Nephrol, 20, pp.2098~2103 (2009)
5. Pinter I, "Analgesic nephropathy in Hungary: the HANS study", Nephrol Dial Transplant, 19, pp.840~843 (2004)
6. Bennett WM, "Analgesic nephropathy: a preventable renal disease", N Engl J Med, 320, pp.1269~1271 (1989)
7. Delzell E, "A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease", Medicine (Baltimore), 77, pp.102~121 (1998)
8. Dubach UC, "An epidemiologic study of abuse of analgesic drugs: effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987)", N Engl J Med, 324, pp.155~160 (1991)
9. Mihatsch MJ, "Obituary to analgesic nephropathy:an autopsy study", Nephrol Dial Transplant, 21, pp.3139~3145 (2006)
10. Noels LM, "Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium", Nephrol Dial Transplant, 10, pp.167~174 (1995)
11. Brunner FP, "End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTAERA Registry Committee", Nephrol Dial Transplant, 9, pp.1371~1376 (1994)
12. Gault MH, "Analgesic nephropathy in Canada: clinical syndrome, management, and outcome", Kidney Int, 13, pp.58~63 (1978)
13. Mabeck CE, "Mortality from chronic interstitial nephritis and phenacetin consumption in Denmark", Acta Med Scand, 205, pp.599~601 (1979)
14. Nanra RS, "Analgesic nephropathy in the 1990s: an Australian perspective", Kidney Int Suppl, 42, pp.S86~S92 (1993)
15. Wilson DR, "Declining incidence of analgesic nephropathy in Canada", Can Med Assoc J, 127, pp.500~502 (1982)
16. Michielsen P, "Trends of analgesic nephropathy in two high-endemic regions with different legislation", J Am Soc Nephrol, 12, pp.550~556 (2001)
17. Kincaid-Smith P, "Analgesic nephropathy", Kidney Int, 13, pp.1~4 (1978)
18. Dubach UC, "Epidemiologic study of abuse of analgesics containing phenacetin: renal morbidity and mortality (1968-1979)", N Engl J Med, 308, pp.357~362 (1983)
19. McCredie M, "The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure", Clin Nephrol, 31, pp.35~39 (1989)
20. Pan Y, "Status of non-steroidal antiinflammatory drugs use and its association with chronic kidney disease:a cross-sectional survey in China", Nephrology (Carlton), 19, pp.655~660 (2014)
21. Prescott LF, "Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics", Drugs, 23, pp.75~149 (1982)
22. Stewart JH, "Analgesic abuse and kidney disease", Aust N Z J Med, 6, pp.498~508 (1976)
23. Henrich WL, "Analgesic nephropathy", Am J Med Sci, 295, pp.561~568 (1988)
24. Curhan GC, "Lifetime nonnarcotic analgesic use and decline in renal function in women", Arch Intern Med, 164, pp.1519~1524 (2004)
25. Sandler DP, "Analgesic use and chronic renal disease", N Engl J Med, 320, pp.1238~1243 (1989)
26. Perneger TV, "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs", N Engl J Med, 331, pp.1675~1679 (1994)
27. Steenland NK, "Occupational and other exposures associated with male end-stage renal disease: a case", control study, 1990, pp.80, 153~157
28. Kelkar M, "Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims", J Manag Care Pharm, 18, pp.234~246 (2012)
29. Agodoa LY, "Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults", Am J Kidney Dis, 51, pp.573~583 (2008)
30. Ferguson I, "Aspirin, phenacetin, and the kidney: a rheumatism clinic study", Med J Aust, 1, pp.950~954 (1977)
31. Caughey DE, "Aspirin and the kidney. New Zealand Rheumatism Association Study", Br Med J, 1, pp.593~596 (1974)
32. Rexrode KM, "Analgesic use and renal function in men", JAMA, 286, pp.315~321 (2001)
33. Okada S, "Is long-term low-dose aspirin therapy associated with renal dysfunction in patients with type 2 diabetes? JPAD2 Cohort Study", PLoS One, 11, pp.e0147635~ (2016)
34. Ibanez L, "Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease", Kidney Int, 67, pp.2393~2398 (2005)
35. Macklon AF, "Aspirin and analgesic nephropathy", Br Med J, 1, pp.597~600 (1974)
36. Emkey RD, "Aspirin and analgesic nephropathy", JAMA, 247, pp.55~57 (1982)
37. Elseviers MM, "A long-term prospective controlled study of analgesic abuse in Belgium", Kidney Int, 48, pp.1912~1919 (1995)
38. Fored CM, "Acetaminophen, aspirin, and chronic renal failure", N Engl J Med, 345, pp.1801~1808 (2001)
39. Ingrasciotta Y, "Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study", PLoS One, 10, pp.e0122899~ (2015)
40. Van der Woude FJ, "Analgesics use and ESRD in younger age: a case-control study", BMC Nephrol, 8, pp.15~ (2007)
41. Michielsen P, "Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study", Nephrol Dial Transplant, 24, pp.1253~1259 (2009)
42. Sandler DP, "Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease", Ann Intern Med, 115, pp.165~172 (1991)
43. Gooch K, "NSAID use and progression of chronic kidney disease", Am J Med, 120(280), pp.280.e1~280.e7 (2008)
44. Nderitu P, "Non-steroidal antiinflammatory drugs and chronic kidney disease progression: a systematic review", Fam Pract, 30, pp.247~255 (2013)
45. Josephy D, "Molecular toxicology" (2006), Oxford University Press
46. Lanes SF, "Analgesics and kidney disease", Int J Epidemiol, 15, pp.454~455 (1986)
47. Henrich WL, "Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation", Am J Kidney Dis, 27, pp.162~165 (1996)
48. Feinstein AR, "Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy", Kidney Int, 58, pp.2259~2264 (2000)

관련 논문AI추천